BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/21/2021 10:09:50 PM | Browse: 128 | Download: 208
Category |
Oncology |
Manuscript Type |
Evidence Review |
Article Title |
New frontiers in focal therapy for prostate cancer: Prostate-specific membrane antigen positron emission tomography/magnetic resonance imaging
|
Manuscript Source |
Invited Manuscript |
All Author List |
Celeste Manfredi, Esaú Fernández-Pascual, Estefanía Linares-Espinós, Felipe Couñago and Juan Ignacio Martínez-Salamanca |
Funding Agency and Grant Number |
|
Corresponding Author |
Juan Ignacio Martínez-Salamanca, MD, PhD, Associate Professor, Department of Urology, Hospital Universitario Puerta Hierro-Majadahonda, Calle Manuel de Falla 1, Majadahonda 28222, Madrid, Spain. jims09@me.com |
Key Words |
Prostate-specific membrane antigen; Positron emission tomography/magnetic resonance imaging; Prostate cancer; Focal therapy; High-intensity focused ultrasound; Cryotherapy |
Core Tip |
Prostate-specific membrane antigen positron emission tomography/magnetic resonance imaging can be an effective imaging modality for detecting primary and recurrent prostate cancer, besides it seems to provide accurate local staging and restaging. Multiparametric magnetic resonance imaging is considered the standard imaging modality in the context of focal therapy; however, the diagnostic performance of prostate-specific membrane antigen positron emission tomography/magnetic resonance imaging make it an excellent candidate as a technique of choice in this setting. |
Citation |
Manfredi C, Fernández-Pascual E, Linares-Espinós E, Couñago F, Martínez-Salamanca JI. New frontiers in focal therapy for prostate cancer: Prostate-specific membrane antigen positron emission tomography/magnetic resonance imaging. World J Clin Oncol 2021; 12(2): 61-68 |
|
Received |
|
2020-10-10 19:05 |
|
Peer-Review Started |
|
2020-10-10 19:06 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-11-12 23:23 |
|
Revised |
|
2020-11-16 21:51 |
|
Second Decision |
|
2021-01-12 06:50 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-01-21 22:09 |
|
Articles in Press |
|
2021-01-21 22:09 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-02-01 05:33 |
ISSN |
2218-4333 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345